Seastar Medical Holding Corp (ICU) - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K, dated August 14, 2023, serves as a current report for SeaStar Medical Holding Corporation. The filing references a press release (Exhibit 99.1) announcing the Company's financial condition and results of operations for the fiscal quarter ended June 30, 2023.
Key Financial Metrics
The provided text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The filing explicitly states that the detailed financial data is contained within the press release furnished as Exhibit 99.1, which is not included in the source text provided.
Material Changes
The filing text does not provide specific details regarding material changes versus the prior comparable period. It only confirms the issuance of a report covering the quarter ended June 30, 2023.
Guidance, Outlook, and Risks
The text does not include specific management commentary, forward-looking guidance, risk factors, or contingencies. It notes that the information in this report, including the referenced press release, is deemed "furnished" and not "filed" for purposes of Section 18 of the Exchange Act, meaning it is not subject to the liabilities of that section and shall not be deemed incorporated by reference into other filings.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated August 14, 2023) for actual revenue, net income, and cash flow figures.
- Verify the specific details of the financial condition and operational results for the quarter ended June 30, 2023.
- Confirm any forward-looking statements or guidance provided in the separate press release.
- Note that this 8-K filing itself does not contain the numerical data required for financial analysis.